Fady Shanouda – The Conversation

Following news of Ozempic’s ability to help its users lose weight, it did not take long for fat-haters to surface. (Justin Katigbak/Disabled And Here)

August 23, 2023

Ozempic, the ‘miracle drug,’ and the harmful idea of a future without fat

Fady Shanouda, Carleton University and Michael Orsini, L’Université d’Ottawa/University of Ottawa

The messaging around Ozempic being a miracle cure is not only a lie, it has kicked up a new level of fatphobia.

Ozempic, a semaglutide drug being used for weight loss, could impact how society sees fat people. (macrovector/Freepik)

June 22, 2023

Listen: Widespread use of Ozempic for weight loss could change how we view fatness

Boké Saisi, The Conversation; Kikachi Memeh, The Conversation, and Vinita Srivastava, The Conversation

As the use of Ozempic, a drug for diabetes, slams into the mainstream as a weight-loss method, will the drug’s use impact our concept of fatness? And how does fatness intersect with race and class?

Jonathan Marchand, a 43-year-old man living with muscular dystrophy, protested in a cage near the Québec legislature, in Québec City, on Aug. 13, 2020. THE CANADIAN PRESS/Mathieu Belanger

January 12, 2022

Warehousing disabled people in long‑term care homes needs to stop. Instead, nationalize home care.

Kelly Fritsch, Carleton University and Fady Shanouda, Carleton University

We must support disabled people’s call to abolish long-term care and develop a national home care, palliative care and pharmacare system that funds and prioritizes their desire to live in communities.

Contact Fady for